MLM On Other Exchanges
Symbol
Exchange
BrsaItaliana
Frankfurt
text size: T | T
Back to Snapshot
Company Description

Contact Info

Via Olgettina, 58

Milan, MI 20132

Italy

Phone: 39 02 21 27 71

Fax: 39 02 21 27 73 25

MolMed S.p.A., a medical biotechnology company, focuses on the research, development, and clinical validation of anticancer therapies. The company’s products include Zalmoxis (TK), a cell based therapy product, which is in Phase III clinical trial in acute leukemia that is used for the treatment of hematological malignancies. Its products also comprise NGR-hTNF, a therapeutic agent for solid tumors, which is in Phase II trials in seven types of solid tumors, such as monotherapy in colorectal cancer, hepatocellular carcinoma, and mesothelioma; and in combination with standard chemotherapeutic agents in small-cell lung cancer, non-small cell lung cancer, ovarian cancer, and soft-tissue sarcoma, as well as in Phase III trials in mesothelioma patients. In addition, the company’s preclinical development products include CAR-CD44v6, an immuno-gene therapy project for the treatment of various hematological malignancies and epithelial tumors. Further, it conducts cell and gene therapy projects in collaboration with third parties, such as the cGMP production of clinical-grade viral vectors; and manufacturing of patient-specific genetically engineered cells. The company was founded in 1996 and is headquartered in Milan, Italy.

 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

MLM Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for MLM.
View Industry Companies
 

Industry Analysis

MLM

Industry Average

Valuation MLM Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 7.1x
Price/Book 6.1x
Price/Cash Flow NM Not Meaningful
TEV/Sales 6.0x
 | 

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact MOLECULAR MEDICINE SPA, please visit www.molmed.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.